Kapstone Financial Advisors LLC Novartis Ag Transaction History

Kapstone Financial Advisors LLC

  • $165 Billion
  • Q3 2024

A detailed history of Kapstone Financial Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Kapstone Financial Advisors LLC holds 2,695 shares of NVS stock, worth $265,161. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,695
Previous 2,695 -0.0%
Holding current value
$265,161
Previous $287 Million 8.59%
% of portfolio
0.19%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023
BUY
$92.52 - $104.91 $249,341 - $282,732
2,695 New
2,695 $278 Million
Q4 2022

Feb 15, 2023
BUY
$75.55 - $92.52 $196,052 - $240,089
2,595 New
2,595 $223 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kapstone Financial Advisors LLC Portfolio

Follow Kapstone Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kapstone Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kapstone Financial Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email